StockData
Prime Medicine, Inc. logo

Prime Medicine, Inc. (PRME) income statement

PRMENasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$3.55−0.29 (-7.55%)

Close on Nov 20, 2026Market cap $643.89MP/E –Yield –

See a number that looks wrong?